Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model
NCT01134328
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Conjunctivitis
Interventions
DRUG:
AC-150 Combo
DRUG:
AC-150A 0.1%
DRUG:
AC-150B 0.005%
DRUG:
Vehicle
Sponsor
Aciex Therapeutics, Inc.